Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Management of CAR T-Cell Toxicities: Concordance and Divergence between Healthcare Providers and Expert Consensus Recommendations

Matthew Frigault, MD MSc, Megan Cartwright, PhD, Krista Marcello, BA, Timothy A Quill, PhD, Daniel J. DeAngelo, MD PhD, Ilene Galinsky, Shilpa Paul, PharmD, Jae H. Park, MD

Blood (2019) 134 (Supplement_1): 2199.

https://doi.org/10.1182/blood-2019-131533

Published: 2019

Journal Articles

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Michael S Broder, MD MSHS, Qiufei Ma, PhD, Tingjian Yan, PhD, Eunice Chang, PhD, Lamis K. Eldjerou, MD, Yanni Hao, PhD, David Kuzan, MD, Jie Zhang, PhD

Blood (2019) 134 (Supplement_1): 4719.

https://doi.org/10.1182/blood-2019-122587

Published: 2019

Journal Articles

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors-Related Hematological Toxicities in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Bradley J. Grant, JD, Anita Sultan, MD, Nicholas D'Cunha, MD, Chandler Graf, Sriman Swarup, MDMBBS, Myint Aung Win, MDMBBS, Ei Moe Phyu, MD, Thura Win Htut, MBBS, MRCP, Myat Min Han, MD, Yin Mon Myat, MD, Nimesh Adhikari, MD, Nyein Htway Yu, MBBS, MD, Donald P. Quick, MD, Kyaw Zin Thein, MDMBBS

Blood (2019) 134 (Supplement_1): 5877.

https://doi.org/10.1182/blood-2019-123531

Published: 2019

Journal Articles

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 361.

https://doi.org/10.1182/blood-2018-99-110500

Published: 2018

Journal Articles

Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition

Ferras Alashkar, MD, Doerte Herich-Terhuerne, Nicole Preising, Ulrich Duehrsen, MD, Vogel Ulrich, MD, Alexander Röth, MD

Blood (2018) 132 (Supplement 1): 3817.

https://doi.org/10.1182/blood-2018-99-118968

Published: 2018

Journal Articles

Pembrolizumab for the Treatment of Disease Relapse Following Allogeneic Hematopoietic Cell Transplantation

Justin Kline, MD, Hongtao Liu, MD PhD, Tallarico Michael, MD, Andrew S Artz, MD, James Godfrey, MD, Emily K Curran, MD, Wendy Stock, MD, Sonali M. Smith, MD, Michael R. Bishop, MD

Blood (2018) 132 (Supplement 1): 3415.

https://doi.org/10.1182/blood-2018-99-115108

Published: 2018

Journal Articles

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2848.

https://doi.org/10.1182/blood.V130.Suppl_1.2848.2848

Published: 2017

Journal Articles

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Aida Siyahian, Heeyoung Kim, MS, Jennifer Berano Teh, Howard Chang, Liezl Atencio, Alicia Gonzales, F. Lennie Wong, PhD, Ryotaro Nakamura, MD, Canlan Sun, PhD, Saro Armenian, DO, MPH

Blood (2016) 128 (22): 5799.

https://doi.org/10.1182/blood.V128.22.5799.5799

Published: 2016

Journal Articles

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Maria Creignou, MD, Hannah Bower, MSc, Therese M-L Andersson, MSc PhD, Anna Ravn Landtblom, MD, Paul W Dickman, MSc PhD, Magnus Björkholm, MD, PhD, Sigurdur Y Kristinsson, MD, PhD, Malin Hultcrantz, MDPhD

Blood (2016) 128 (22): 946.

https://doi.org/10.1182/blood.V128.22.946.946

Published: 2016

Journal Articles

Suicide in European Hodgkin Lymphoma Patients

Austin Kim, MD, Andreas Engert, MD, Helen Gorgen, Louise Maranda, PhD, Ann S LaCasce, MD, Sven Borchmann, MD

Blood (2016) 128 (22): 2995.

https://doi.org/10.1182/blood.V128.22.2995.2995

Published: 2016

Journal Articles

Impact of Long-Term Tyrosine Kinase Inhibitor Exposure on Spermatogenesis in Juvenile Rats

Vera Girke, Josephine Tabea Tauer, PhD, Ingmar Glauche, PhD, Lorenz Hofbauer, MD PhD, Meinolf Suttorp, MD PhD

Blood (2016) 128 (22): 1884.

https://doi.org/10.1182/blood.V128.22.1884.1884

Published: 2016

Journal Articles

Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk

Lawrence F. Kuklinski, BA, Shufeng Li, MS, Margaret R. Karagas, PhD, Bernice Y. Kwong, MD, Wen-Kai Weng, MD PhD

Blood (2016) 128 (22): 2249.

https://doi.org/10.1182/blood.V128.22.2249.2249

Published: 2016

Journal Articles

Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab

Alexander Roeth, MD, Ferras Alashkar, MD, Doerte Herich-Terhuerne, Johannes Elias, MD, Ulrich Vogel, MD, Ulrich Duehrsen

Blood (2014) 124 (21): 4380.

https://doi.org/10.1182/blood.V124.21.4380.4380

Published: 2014

Journal Articles

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Unell Riley, Mark Ethell, MD, Michael N Potter, MD PhD

Blood (2014) 124 (21): 1140.

https://doi.org/10.1182/blood.V124.21.1140.1140

Published: 2014

Journal Articles

The Clinical Significance of Minimal Residual Disease Detected By Multiparametric Flow Cytometry in Acute Leukemia

Fen Huang, Hui Jing, Zhengshan Yi, Xiaolei Wei, PhD, Zhongxin Zheng, Muchen Xie, Ru Feng, MD

Blood (2014) 124 (21): 5261.

https://doi.org/10.1182/blood.V124.21.5261.5261

Published: 2014

Journal Articles

Risk Factors for Inpatient Acute Venous Thromboembolism (VTE) Despite Thromboprophylaxis.

Tzu-Fei Wang, MD, Catherine A Wong, MPH, MT (ASCP), Paul Milligan, PharmD, Mark S Thoelke, MD, SFHM, Keith F Woeltje, MD, PhD, Brian F Gage, MD, MSc

Blood (2012) 120 (21): 2248.

https://doi.org/10.1182/blood.V120.21.2248.2248

Published: 2012

Journal Articles

Gonadal Function In Patients with Beta-Thalassemia Major Following Bone Marrow Transplantation,

Khalil Al Farsi, BSc MD ABIM FRCPC, Murtadha K. Al-Khabori, MD, FRCPC, Fehmida Zia, MBBS, Moez Abdul-Rahim, MBBS, Yusra Al-Habsi, BSc, Eman Al-Manthari, BSc, J. David Dennison, MD, Shahina Daar, MD, PhD

Blood (2011) 118 (21): 4105.

https://doi.org/10.1182/blood.V118.21.4105.4105

Published: 2011

Journal Articles

Dexamethasone Therapy for Acute Lymphoblastic Leukemia Increases Sleep During the Night and During the Day In Young Children

Anne Harris, B.A., Gerald Rosen, M.D., Meixia Liu, M.S., James Krueger, Ph.D., Yoav Messinger, M.D.

Blood (2010) 116 (21): 258.

https://doi.org/10.1182/blood.V116.21.258.258

Published: 2010

Journal Articles

Recombinant Activated Factor VII (rFVIIa) in the Treatment of Non-Hemophilia Patients: Physician Underreporting of Thromboembolic Adverse Events.

Cyrus C. Hsia, MD, FRCPC, Joanna H. Zurawska, Michael Z.Y. Tong, MD, Kathleen Eckert, MLT, ART, Vivian C. McAlister, MD, FRCSC, Ian H. Chin-Yee, MD, FRCPC

Blood (2007) 110 (11): 3143.

https://doi.org/10.1182/blood.V110.11.3143.3143

Published: 2007

Journal Articles

Severe Gemcitabine-Associated Lung Injury in Hodgkins Disease & Other Cancers: Reporting Quality and Clinical Characteristics of Cases Reported in the Medical Literature and to the FDA.

Steven M. Belknap, MD, Nicolas Slimack, BA, Timothy Kuzel, MD, Kenneth R. Carson, MD, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Steven M. Trifilio, PharmD, Charles L. Bennett, MD

Blood (2004) 104 (11): 3145.

https://doi.org/10.1182/blood.V104.11.3145.3145

Published: 2004

NARROW

Management of CAR T-Cell Toxicities: Concordance and Divergence between Healthcare Providers and Expert Consensus Recommendations

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors-Related Hematological Toxicities in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition

Pembrolizumab for the Treatment of Disease Relapse Following Allogeneic Hematopoietic Cell Transplantation

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Incidence and Predictors of Late-Occurring Central Nervous System Complications in Allogeneic Hematopoietic Cell Transplant Survivors

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Suicide in European Hodgkin Lymphoma Patients

Impact of Long-Term Tyrosine Kinase Inhibitor Exposure on Spermatogenesis in Juvenile Rats

Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk

Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

The Clinical Significance of Minimal Residual Disease Detected By Multiparametric Flow Cytometry in Acute Leukemia

Risk Factors for Inpatient Acute Venous Thromboembolism (VTE) Despite Thromboprophylaxis.

Gonadal Function In Patients with Beta-Thalassemia Major Following Bone Marrow Transplantation,

Dexamethasone Therapy for Acute Lymphoblastic Leukemia Increases Sleep During the Night and During the Day In Young Children

Recombinant Activated Factor VII (rFVIIa) in the Treatment of Non-Hemophilia Patients: Physician Underreporting of Thromboembolic Adverse Events.

Severe Gemcitabine-Associated Lung Injury in Hodgkins Disease & Other Cancers: Reporting Quality and Clinical Characteristics of Cases Reported in the Medical Literature and to the FDA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only